Clinical trial · Interventional
Neopep-S-based EasyDew MD Regen Cream for Radiotherapy Subject After Breast Tumor Resection
Researcher-led Clinical Study to Evaluate the Effectiveness and Safety of the Application of Neopep-S-based Easy Dew MD Regen Cream in Patients Under Radiotherapy After Breast Tumor Resection
NCT06025058CI-TRIAL-00069360completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical study is conducted prospectively for 3 months after medical device treatment. It is a comparative clinical study of the leading control group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Lesion | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Easy Dew MD Regen Cream | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Easy Dew MD Regen Cream
- description
- In the case of the study group among the subjects of the clinical study, The experimental group apply an appropriate amount of EasyDew MD Regen Cream twice a day (morning and evening) and can be absorbed well.
- interventionNames
- Device: Easy Dew MD Regen Cream
- type
- ACTIVE_COMPARATOR
- label
- Physiogel Stability Intensive Cream MD
- description
- The subject applies the provided medical device twice a day (morning and evening) to areas with symptoms of dry skin so that it can be absorbed well.
- interventionNames
- Device: Easy Dew MD Regen Cream
Primary outcomes (1)
- measure
- Transepidermal water loss
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * adults over the age of 19 * The tumor in the breast area is resected and radiotherapy is planned, performed, or Subjects with a history of irradiation * Decide to participate in this clinical study arbitrarily and in the written informed consent a person to whom Exclusion Criteria: * When participating in a clinical study, the findings of radiation dermatitis in the area are shown * A person who shows signs of acute or chronic dermatological diseases * In situations where the requirements of a clinical study cannot be complied with * When the researcher's judgment determines that the participation of the study is inappropriate (e.g. Kelloid personality)
References
Publications (0)
Data not yet available
No reference posted for this study.